Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome.
<h4>Background</h4>Numerous preclinical studies have supported the theory that enhanced activation of mGluR5 signaling, due to the absence or reduction of the FMR1 protein, contributes to cognitive and behavioral deficits in patients with fragile X syndrome (FXS). However multiple phase...
Main Authors: | David Hessl, Danielle Harvey, Stephanie Sansone, Crystal Crestodina, Jamie Chin, Reshma Joshi, Randi J Hagerman, Elizabeth Berry-Kravis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0209984 |
Similar Items
-
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
by: Randi Hagerman, et al.
Published: (2018-11-01) -
Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
by: Knox Andrew, et al.
Published: (2012-02-01) -
Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
by: Skylar Luu, et al.
Published: (2020-09-01) -
Best Practices in Fragile X Syndrome Treatment Development
by: Craig A. Erickson, et al.
Published: (2018-12-01) -
Fragile X and autism: Intertwined at the molecular level leading to targeted treatments
by: Hagerman Randi, et al.
Published: (2010-09-01)